Evidence map›Paper›PMID 34083450›Full record

ArticleScience (New York, N.Y.)2021

Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders.

Simone Brioschi, Wei-Le Wang, Vincent Peng, Meng Wang, Irina Shchukina, Zev J Greenberg, Jennifer K Bando, Natalia Jaeger, Rafael S Czepielewski, Amanda Swain and 15 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 310 papers.

0numbers the graph read from it
0cells of the map it votes in
310citing papers in PubMed
29.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05849805 nacompletednot on this mapstarted 2023, after this paper: background citation

The Feasibility, Safety and Efficacy of Y-3 Injection Through Skull Bone Marrow Bypassing Blood-brain Barrier in the Treatment of Acute Malignant Middle Cerebral Artery Infarction(SOLUTION)

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2024Enrolled20ConditionsStroke, Acute IschemicArmsIntracalvaria bone marrow injection, Conventional treatment
NCT07514949 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device

TypeinterventionalSponsoryilong WangRan2026 to 2026Enrolled6ConditionsStroke, Acute Ischemic Stroke, Blood-Brain BarrierArmsRK-4 ICO injection, Conventional treatment
3 · Its place in the literature

Who cites it

310 citing papers in PubMed, 429 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

250 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 1 country.

Simone Brioschi *Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-3849-3926
Wei-Le Wang *Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-6984-4514
Vincent Peng *Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-0301-2985
Meng WangInterdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511, USA.ORCID 0000-0002-3453-7805
Irina ShchukinaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Zev J GreenbergDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-6234-7005
Jennifer K BandoDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-1331-7424
Natalia JaegerDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0003-2875-8297
Rafael S CzepielewskiDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-2475-3838
Amanda SwainDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0003-0683-368X
Denis A MogilenkoDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0001-5427-5243
Wandy L BeattyDepartment of Molecular Microbiology, Center for Infectious Disease Research, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0003-0715-7361
Peter BayguinovWashington University Center for Cellular Imaging, Washington University School of Medicine, Saint Louis, MO 63110, USA.
James A J FitzpatrickWashington University Center for Cellular Imaging, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-7907-3602
Laura G SchuettpelzDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Catrina C FronickMcDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-2766-9551
Igor SmirnovDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Jonathan KipnisDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-3714-517X
Virginia S ShapiroDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-9978-341X
Gregory F WuDepartment of Neurology, Washington University in Saint Louis, Saint Louis, MO 63110, USA.ORCID 0000-0003-3588-0637
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0003-1672-0996
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0003-1230-1313
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-1133-4212
Steven H KleinsteinInterdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511, USA.ORCID 0000-0003-4957-1544
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA. mcolonna@wustl.edu.ORCID 0000-0001-5222-4987
Washington University in St. Louis · USYale University · USJames S. McDonnell Foundation · USMayo Clinic · USStanford University · US

Funding

Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Christine T. Pham · 2018 to 2026
$7.6M
Pediatric Gastroenterology Research Training ProgramT32DK077653 · NIDDK · WASHINGTON UNIVERSITY · PI PHILLIP I TARR · 2007 to 2026
$5.8M
COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTSR01AI104739 · NIAID · YALE UNIVERSITY · PI KLEINSTEIN, STEVEN H. · 2014 to 2022
$3.6M
TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASERF1AG051485 · NIA · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2015 to 2021
$3.5M
THERAPEUTIC STRATEGIES FOR ALZHEIMER'S DISEASE BASED ON TREM2 BIOLOGYRF1AG059082 · NIA · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2019 to 2019
$2.6M
Immune Checkpoints for Intestinal Innate Lymphoid CellsK99DK118110 · NIDDK · WASHINGTON UNIVERSITY · PI BANDO, JENNIFER KAORU · 2019 to 2020
$182k
Determining the contribution of polyamine biosynthesis to the function of group 3 innate lymphoid cells in the gastrointestinal systemF30DK127540 · NIDDK · WASHINGTON UNIVERSITY · PI PENG, VINCENT · 2020 to 2022
$106k
NIAID NIH HHS R01 AI104739NIAMS NIH HHS P30 AR073752NIA NIH HHS RF1 AG051485NIA NIH HHS RF1 AG059082NIDDK NIH HHS F30 DK127540NIDDK NIH HHS K99 DK118110NIDDK NIH HHS T32 DK077653
6 · The paper itself

Abstract

The meninges contain adaptive immune cells that provide immunosurveillance of the central nervous system (CNS). These cells are thought to derive from the systemic circulation. Through single-cell analyses, confocal imaging, bone marrow chimeras, and parabiosis experiments, we show that meningeal B cells derive locally from the calvaria, which harbors a bone marrow niche for hematopoiesis. B cells reach the meninges from the calvaria through specialized vascular connections. This calvarial-meningeal path of B cell development may provide the CNS with a constant supply of B cells educated by CNS antigens. Conversely, we show that a subset of antigen-experienced B cells that populate the meninges in aging mice are blood-borne. These results identify a private source for meningeal B cells, which may help maintain immune privilege within the CNS.

Indexed as

LymphopoiesisAgingAnimalsB-LymphocytesB-Lymphocyte SubsetsBone Marrow CellsCell MovementCentral Nervous SystemDura MaterFibroblastsHomeostasisImmune PrivilegeMeningesMicePlasma CellsSingle-Cell Analysis

Identifiers

PMID34083450
PMCPMC8448524
OpenAlexW3165520347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.